COPD is a major drain on health-care budgets with 50% of costs accounted for by hospital admissions http://bit.ly/3F0ZMY
It is time to define the disorders of the syndrome of COPD, and clearly distinguish COPD from asthma. Post-bronchodilator FEV1/FVC ratio of below 0·7 identifies patients with poorly reversible airflow obstruction helps distinguish COPD from asthma. http://bit.ly/SfGjK
COPD mortality is inversely correlated to the forced expiratory volume (FEV1) in 1 second. http://bit.ly/ZYIR7
BODE index (body-mass index, airflow obstruction, dyspnoea, exercise capacity) is a prognostic assessment of COPD patients. A simplified ADO index (including age, dyspnoea, and airflow obstruction) was developed from BODE index for COPD http://bit.ly/14IUDL
Budesonide treatment for 12 months does not increase the risk of pneumonia in patients with COPD http://bit.ly/1PntiS
Different subsets of patients exist within the broad spectrum of COPD, targeted specific therapies could help http://bit.ly/3nuGuR
Frequent exacerbations in COPD: What to do? BMJ 10-minute consultation, 2011.